title: CD98 activation increases surface expression and clusteringof beta1 integrins in MCF-7 cells through FAK/Src- and cytoskeleton-independent mechanisms.
abstract: CD98, a disulfide-linked 125-kDa heterodimeric type II transmembrane glycoprotein, regulates beta1 integrin- mediated cell adhesion. However, the molecular mechanisms underlying CD98-mediated activation of beta1 integrin are presently unclear. In this study, the effects of CD98 signaling on the expression and clustering of beta1 integrin were investigated. Activation of CD98 augmented surface expression of beta1 integrin on MCF-7 cells. Cross-linking CD98 induced clustering of beta1 integrins. Inhibition of phosphorylation of focal adhesion kimase (FAK) by PP2, an inhibitor of Src family kinase, reduced cell-extracellular matrix adhesion, but not surface expression and clustering of beta1 integrin on MCF-7 cells. This result was confirmed by over-expression of dominant negative forms of FAK. In addition, phalloidin or cytochalasin D inhibited CD98-mediated induction of cell-ECM adhesion, but not surface expression and clustering of beta1 integrins. The inhibitory effects of PP2, cytochalasin D or phalloidin on CD98-stimulated cell adhesion were diminished by pretreatment of cells with Mn2+, which is shown to induce conformational change of integrins. These results provide the first evidence that CD98 activation increases not only beta1 integrin affinity but also its surface expression and clustering and the latter is independent of FAK/Src and cytoskeleton.
authors.affiliation: Department of Anatomy and Cell Biology, College of Medicine, Vascular System Research Center, Research Institute of Life Sciences, Kangwon National University, Chunchon 200-701, Korea.
authors.forename: Sun Mi
authors.initials: SM
authors.lastname: Kim
authors.forename: Jang Hee
authors.initials: JH
authors.lastname: Hahn
mesh_terms: D045744:Cell Line, Tumor; D015638:Cytochalasin D / Q000494:pharmacology; D003599:Cytoskeleton / Q000187:drug effects / Q000201:enzymology; D051418:Focal Adhesion Kinase 2 / Q000235:genetics / Q000378:metabolism*; D022001:Focal Adhesions / Q000187:drug effects / Q000201:enzymology; D027261:Fusion Regulatory Protein-1 / Q000819:agonists / Q000378:metabolism*; D006801:Humans; D019012:Integrin beta1 / Q000096:biosynthesis* / Q000235:genetics; D018613:Microscopy, Confocal; D046912:Multiprotein Complexes / Q000096:biosynthesis* / Q000235:genetics; D050505:Mutant Proteins / Q000235:genetics / Q000378:metabolism; D010590:Phalloidine / Q000494:pharmacology; D010766:Phosphorylation / Q000187:drug effects; D011485:Protein Binding; D011743:Pyrimidines / Q000494:pharmacology; D015398:Signal Transduction / Q000502:physiology; D014162:Transfection
chemical_list: C412373:AG 1879; D027261:Fusion Regulatory Protein-1; D019012:Integrin beta1; D046912:Multiprotein Complexes; D050505:Mutant Proteins; D011743:Pyrimidines; D010590:Phalloidine; D015638:Cytochalasin D; D051418:Focal Adhesion Kinase 2